Sign In
Buy GLYC
$15.71
+0 (+0%)
At Close: Oct 01, 2025
GlycoMimetics (NASDAQ:GLYC) Upgraded to Buy by Zacks Investment Research
10:34am, Monday, 13'th Apr 2020
Zacks Investment Research upgraded shares of GlycoMimetics (NASDAQ:GLYC) from a hold rating to a buy rating in a report released on Thursday, Zacks.com reports. The firm currently has $2.75 target pri
Analysts Set GlycoMimetics Inc (NASDAQ:GLYC) Target Price at $8.75
10:08am, Thursday, 09'th Apr 2020
GlycoMimetics Inc (NASDAQ:GLYC) has been assigned an average recommendation of “Buy” from the nine brokerages that are covering the company, MarketBeat reports. One investment analyst has rated th
GlycoMimetics Appoints Dr. Myra Rosario Herrle as Vice President, Regulatory Affairs
01:15pm, Tuesday, 07'th Apr 2020
GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that veteran regulatory expert Myra Rosario Herrle, PhD, RPh, RAC, has joined the executive management team as Vice President, Regulatory Affairs.
GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
08:15pm, Monday, 06'th Apr 2020
GlycoMimetics, Inc. (the "Company") (NASDAQ:GLYC) today announced that the compensation committee of the Company’s Board of Directors approved the grant on April 1, 2020 of non-qualified stock optio
Breite Allianz von Forschungsinstituten baut COVID-19 Test-Infrastruktur
12:00pm, Friday, 03'rd Apr 2020
Die Bewältigung der COVID-19 Pandemie stellt eine noch nie dagewesene Herausforderung für das Gesundheitssystem und die Volkswirtschaft Österreichs dar. 20 Wiener Forschungsinstitute wollten …
GlycoMimetics Inc (NASDAQ:GLYC) Expected to Post Earnings of -$0.34 Per Share
09:54am, Wednesday, 01'st Apr 2020
Wall Street brokerages forecast that GlycoMimetics Inc (NASDAQ:GLYC) will post earnings of ($0.34) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provi
Every Major Asset Class Ended March Lower. Is It Over?
12:00am, Wednesday, 01'st Apr 2020
Market Overview Analysis by James Picerno covering: Russell 3000 Total Return. Read James Picerno's latest article on Investing.com
GlycoMimetics Inc (NASDAQ:GLYC) Shares Bought by Axa
08:54am, Tuesday, 31'st Mar 2020
Axa boosted its holdings in shares of GlycoMimetics Inc (NASDAQ:GLYC) by 3.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 945
Bank of Montreal Can Grows Stake in GlycoMimetics Inc (NASDAQ:GLYC)
09:50am, Monday, 30'th Mar 2020
Bank of Montreal Can lifted its position in GlycoMimetics Inc (NASDAQ:GLYC) by 149.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 7,413 s
GlycoMimetics (NASDAQ:GLYC) Now Covered by Analysts at Cowen
07:40am, Saturday, 28'th Mar 2020
Equities researchers at Cowen began coverage on shares of GlycoMimetics (NASDAQ:GLYC) in a note issued to investors on Friday, TipRanks reports. The brokerage set a “buy” rating on the biotechnolo
Edited Transcript of GLYC earnings conference call or presentation 28-Feb-20 1:30pm GMT
05:51am, Thursday, 26'th Mar 2020
Q4 2019 GlycoMimetics Inc Earnings Call
In Biotech ‘Cash Is King’ When Wall Street Searches for Value
06:04pm, Wednesday, 25'th Mar 2020
(Bloomberg) -- For investors looking for deals in biotech, Wall Street firms like Baird advise “cash is king.”Losses in the U.S. stock market have decimated many portfolios. And while biotechnolog
Edited Transcript of GLYC earnings conference call or presentation 28-Feb-20 1:30pm GMT
01:19am, Wednesday, 25'th Mar 2020
Q4 2019 GlycoMimetics Inc Earnings Call
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
11:37am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commen
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
